BCL2A1 anticorps (C-Term)
Aperçu rapide pour BCL2A1 anticorps (C-Term) (ABIN926948)
Antigène
Voir toutes BCL2A1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Rat (Rattus), Souris, Boeuf (Vache), Chien, Porc
-
Purification
- Purified
-
Immunogène
- BCL2 A1 antibody was raised in rabbit using the C terminal of BCL2 1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BCL2A1 Blocking Peptide, (ABIN938316), is also available for use as a blocking control in assays to test for specificity of this BCL2A1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BCL2A1 (BCL2-Related Protein A1 (BCL2A1))
-
Autre désignation
- BCL2A1
-
Sujet
- BCL2A1s a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. The protein encoded by this gene is able to reduce the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation. Synonyms: Polyclonal BCL2A1 antibody, Anti-BCL2A1 antibody, BCL2-related protein A1 antibody.
Antigène
-